Overview
Multiple congenital anomalies-hypotonia-seizures syndrome (MCAHS) is a rare genetic disorder that affects multiple body systems from birth. Babies born with this condition typically have low muscle tone (hypotonia), meaning their muscles feel floppy and weak. They also experience seizures that often begin in the first days or weeks of life. In addition, affected children are born with several physical differences (congenital anomalies) that can involve the brain, heart, kidneys, and other organs. There are several subtypes of MCAHS, each caused by changes in different genes involved in a process called glycosylphosphatidylinositol (GPI) anchor biosynthesis. GPI anchors are molecules that attach important proteins to the surface of cells. When this process does not work properly, many body systems can be affected. Children with MCAHS often have intellectual disability, developmental delays, and distinctive facial features. There is currently no cure for MCAHS. Treatment focuses on managing symptoms, including controlling seizures with anti-epileptic medications, providing physical and occupational therapy for low muscle tone, and addressing any organ-specific problems such as heart defects. A team of specialists is usually needed to provide comprehensive care. The severity of the condition varies, but many affected individuals require lifelong support and medical attention.
Key symptoms:
Low muscle tone (floppy muscles) from birthSeizures starting in the newborn periodIntellectual disabilityDelayed development of motor skills like sitting and walkingDelayed speech and language developmentDistinctive facial featuresFeeding difficulties in infancyHeart defects present at birthKidney or urinary tract abnormalitiesBrain abnormalities seen on imagingShort stature or poor growthVision problemsHearing lossJoint contractures or skeletal differencesElevated alkaline phosphatase levels in blood
Clinical phenotype terms (50)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Multiple congenital anomalies-hypotonia-seizures syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Multiple congenital anomalies-hypotonia-seizures syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Multiple congenital anomalies-hypotonia-seizures syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Multiple congenital anomalies-hypotonia-seizures syndrome.
Community
No community posts yet. Be the first to share your experience with Multiple congenital anomalies-hypotonia-seizures syndrome.
Start the conversation →Latest news about Multiple congenital anomalies-hypotonia-seizures syndrome
No recent news articles for Multiple congenital anomalies-hypotonia-seizures syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which specific gene is affected in my child, and what does that mean for their particular form of the condition?,What seizure medications do you recommend, and what side effects should I watch for?,How often should my child have follow-up testing for heart, kidney, and brain health?,What therapies (physical, occupational, speech) should we start, and how often?,Are there any clinical trials or experimental treatments available for this condition?,What is the recurrence risk if we plan to have more children, and is prenatal testing available?,What emergency plan should we have in place for prolonged seizures?
Common questions about Multiple congenital anomalies-hypotonia-seizures syndrome
What is Multiple congenital anomalies-hypotonia-seizures syndrome?
Multiple congenital anomalies-hypotonia-seizures syndrome (MCAHS) is a rare genetic disorder that affects multiple body systems from birth. Babies born with this condition typically have low muscle tone (hypotonia), meaning their muscles feel floppy and weak. They also experience seizures that often begin in the first days or weeks of life. In addition, affected children are born with several physical differences (congenital anomalies) that can involve the brain, heart, kidneys, and other organs. There are several subtypes of MCAHS, each caused by changes in different genes involved in a proc
How is Multiple congenital anomalies-hypotonia-seizures syndrome inherited?
Multiple congenital anomalies-hypotonia-seizures syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Multiple congenital anomalies-hypotonia-seizures syndrome typically begin?
Typical onset of Multiple congenital anomalies-hypotonia-seizures syndrome is neonatal. Age of onset can vary across affected individuals.